CIDP07 Rozanolixizumab Post Trial Access Program (the PTA)
Clinical trial NCT05014724 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT05014724
- Sponsor
- UCB Biopharma SRL
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.